Blood pressure pill showdown: new combo vs. market leader
NCT ID NCT02483936
First seen Dec 12, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This study aimed to compare a new combination of two blood pressure medicines (olmesartan and chlorthalidone) against an existing product (BENICAR HCT®) in adults with high blood pressure. The goal was to see if the new combo worked as well at lowering systolic blood pressure. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.